Tags

Type your tag names separated by a space and hit enter

S-methyl N,N-diethylthiolcarbamate sulfone, an in vitro and in vivo inhibitor of rat liver mitochondrial low Km aldehyde dehydrogenase.
Biochem Pharmacol. 1994 Apr 20; 47(8):1465-7.BP

Abstract

S-Methyl N,N-diethylthiolcarbamate sulfone (DETC-Me sulfone) was investigated for its rat liver mitochondrial low Km aldehyde dehydrogenase (ALDH2) inhibitory properties. DETC-Me sulfone inhibited ALDH2 in vitro (IC50 = 3.8 microM) and in vivo (ID50 = 170 mumol/kg; 31 mg/kg). Maximum inhibition (60%) of ALDH2 was observed 8 hr after DETC-Me sulfone administration. In addition, incubation of S-methyl N,N-diethylthiolcarbamate (DETC-Me) or S-methyl N,N-diethylthiolcarbamate sulfoxide (DETC-Me sulfoxide) with rat liver microsomes and an NADPH-generating system failed to produce DETC-Me sulfone. Furthermore, DETC-Me sulfone could not be detected in plasma from rats treated with either DETC-Me sulfoxide or DETC-Me sulfone. In conclusion, DETC-Me sulfone inhibited ALDH2 in vitro and in vivo. However, there was no evidence suggesting that DETC-Me sulfoxide was metabolized to DETC-Me sulfone.

Authors+Show Affiliations

Department of Pharmacology and Toxicology, University of Kansas Lawrence 60045.No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, U.S. Gov't, P.H.S.

Language

eng

PubMed ID

8185656

Citation

Nagendra, S N., et al. "S-methyl N,N-diethylthiolcarbamate Sulfone, an in Vitro and in Vivo Inhibitor of Rat Liver Mitochondrial Low Km Aldehyde Dehydrogenase." Biochemical Pharmacology, vol. 47, no. 8, 1994, pp. 1465-7.
Nagendra SN, Madan A, Faiman MD. S-methyl N,N-diethylthiolcarbamate sulfone, an in vitro and in vivo inhibitor of rat liver mitochondrial low Km aldehyde dehydrogenase. Biochem Pharmacol. 1994;47(8):1465-7.
Nagendra, S. N., Madan, A., & Faiman, M. D. (1994). S-methyl N,N-diethylthiolcarbamate sulfone, an in vitro and in vivo inhibitor of rat liver mitochondrial low Km aldehyde dehydrogenase. Biochemical Pharmacology, 47(8), 1465-7.
Nagendra SN, Madan A, Faiman MD. S-methyl N,N-diethylthiolcarbamate Sulfone, an in Vitro and in Vivo Inhibitor of Rat Liver Mitochondrial Low Km Aldehyde Dehydrogenase. Biochem Pharmacol. 1994 Apr 20;47(8):1465-7. PubMed PMID: 8185656.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - S-methyl N,N-diethylthiolcarbamate sulfone, an in vitro and in vivo inhibitor of rat liver mitochondrial low Km aldehyde dehydrogenase. AU - Nagendra,S N, AU - Madan,A, AU - Faiman,M D, PY - 1994/4/20/pubmed PY - 1994/4/20/medline PY - 1994/4/20/entrez SP - 1465 EP - 7 JF - Biochemical pharmacology JO - Biochem Pharmacol VL - 47 IS - 8 N2 - S-Methyl N,N-diethylthiolcarbamate sulfone (DETC-Me sulfone) was investigated for its rat liver mitochondrial low Km aldehyde dehydrogenase (ALDH2) inhibitory properties. DETC-Me sulfone inhibited ALDH2 in vitro (IC50 = 3.8 microM) and in vivo (ID50 = 170 mumol/kg; 31 mg/kg). Maximum inhibition (60%) of ALDH2 was observed 8 hr after DETC-Me sulfone administration. In addition, incubation of S-methyl N,N-diethylthiolcarbamate (DETC-Me) or S-methyl N,N-diethylthiolcarbamate sulfoxide (DETC-Me sulfoxide) with rat liver microsomes and an NADPH-generating system failed to produce DETC-Me sulfone. Furthermore, DETC-Me sulfone could not be detected in plasma from rats treated with either DETC-Me sulfoxide or DETC-Me sulfone. In conclusion, DETC-Me sulfone inhibited ALDH2 in vitro and in vivo. However, there was no evidence suggesting that DETC-Me sulfoxide was metabolized to DETC-Me sulfone. SN - 0006-2952 UR - https://www.unboundmedicine.com/medline/citation/8185656/S_methyl_NN_diethylthiolcarbamate_sulfone_an_in_vitro_and_in_vivo_inhibitor_of_rat_liver_mitochondrial_low_Km_aldehyde_dehydrogenase_ L2 - https://linkinghub.elsevier.com/retrieve/pii/0006-2952(94)90350-6 DB - PRIME DP - Unbound Medicine ER -